Clinical trials
Myelodysplastic Syndromes trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Terminated | 6 |
| Enrolling by invitation | 3 |
| Unknown status | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 7 |
| Taiho Oncology, Inc. | 4 |
| Bristol-Myers Squibb | 3 |
| Novartis Pharmaceuticals | 3 |
| Takeda | 3 |
| Pfizer | 2 |
| Ryvu Therapeutics SA | 2 |
| medac GmbH | 2 |
| AbbVie | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 41 |
| Leukemia, Myeloid, Acute | 17 |
| Anemia | 9 |
| Leukemia, Myelomonocytic, Chronic | 6 |
| Recurrence | 4 |
| Thrombocytopenia | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Leukemia | 3 |
| Hematologic Diseases | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
Trials
Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.